Melior Discovery offers comprehensive rodent (mouse and rat) in vivo pharmacology services, providing over 150 efficacy models spanning a wide range of therapeutic areas. With a focus on precision and innovation, we deliver tailored solutions to meet the unique needs of our clients.

Our extensive portfolio includes a diverse array of syngeneic and xenograft oncology models, enabling thorough evaluation of anti-cancer therapies. Additionally, we specialize in inflammation and pain models, boasting several migraine models among our offerings. From metabolic diseases to dermatological conditions and beyond, we provide expertise across various therapeutic domains.

In addition to our robust model catalog, we offer a suite of complimentary services to support every stage of drug discovery and development. Our capabilities encompass pharmacokinetic studies, indications discovery, bioanalytical services, in vivo imaging, histology, and more.

Melior Discovery is proud to offer expertise in handling controlled substances, including Schedule I, providing clients with the assurance of safe and compliant research practices. Partner with us to unlock the full potential of your drug candidates and accelerate your path to clinical success.